293 articles
Jathin Bandari, MD, Chief Medical Officer at Protara Therapeutics, a clinical-stage company committed to identifying and advancing transformative therap...
Nima Farzan, CEO of Kinnate Biopharma Inc., a precision oncology company, discusses the company's investigational targeted cancer therapies which are de...
Sean Bohen, M.D., Ph.D., is President and CEO of Olema Oncology, a company committed to improving outcomes for women living with cancer.
is the Chief Growth Officer at M2GEN, an oncology-focused health informatics solutions company with the mission to help patients get access to the best ...
Shannon Westin, MD, MPH, FACOG, gynecologic oncology physician at Lyndon Baines Johnson Hospital and a Professor in the Department of Gynecologic Oncolo...
Nadim Ahmed, President and CEO of Cullinan Oncology, a clinical-stage biotechnology company developing a diversified pipeline of potential first - and best-in-class targeted therapies for...
Stein, Hematologic Oncologist at Memorial Sloan Kettering Cancer Center discusses the current state of acute myeloid leukemia (AML), the importance of t...
The Astellas Oncology C3 (Changing Cancer Care) Prize is a global challenge that funds and advances the best non-treatment ideas to improve cancer care ...
The Astellas Oncology C3 (Changing Cancer Care) Prize is a global challenge that funds and advances the best non-treatment ideas to improve cancer care ...
Awny Farajallah, M.D., Head of Global Medical Affairs Oncology at Takeda, discusses his transition from physician to head of pharma medical affairs and ...